Skip to main content
SpringerLink
Log in

TIPS for Management of Refractory Ascites: Response and Survival Are Both Unpredictable

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Refractory ascites is a serious complication of advanced cirrhosis with a 1-year transplant-free survival of 20–50%. The aim of our study was to investigate the short- and long-term effects of transjugular intrahepatic portosystemic shunt (TIPS) in the management of refractory ascites. In all 65 patients (39 M, 26 F; Child B 55%, Child C 45%, mean MELD score 14.8 ± 6.6) with liver disease (alcoholic 40%, cryptogenic 20%, HCV 14%, others 26%) and refractory ascites were included in this study. Forty-eight (74%) patients had no signs of hepatic encephalopathy (HE), 16 (24%) had mild and 1 (2%) had moderate HE before TIPS; 28 (43%) had mild (>1.2 and <2.4 mg/dl) and 6 patients (9%) had moderate (>2.4 mg/dl) renal dysfunction. Mean follow-up was 55.5 ± 70.2 weeks. Treatment success, defined as complete response, partial response, and no response, and survival was determined at 3 weeks, and 3, 6, 12, 24, and 36 months after TIPS. TIPS was successful in all patients. Mean portal venous pressure gradient improved significantly after TIPS (24 ± 8 to 10 ± 4). During follow-up, 40 (58%) patients died and 17 (27%) patients had liver transplantation (OLT); 20 (31%) patients had 38 shunt revisions due to lack of initial response or recurrence of ascites. The response was assessed in patients who were alive, without OLT, at each time point. Complete response was seen in 10%, 23%, 17%, 11%, 22% and 33%; partial response was seen in 46%, 46%, 40%, 44%, 28%, and 8%; and no response was seen in 44%, 31%, 43%, 41%, 39%, and 50% at 3 weeks, and 3, 6, 12, 24, and 36 months respectively. There were no pre-TIPS variables that could predict the response at 3 weeks, 3 months, or 6 months. Mild HE was seen in 8 (12%) patients and severe HE was seen in 16 (25%) immediately after TIPS. The mortality at 3 weeks, and 3, 6, 12, 24, and 36 months was 26%, 38%, 46%, 51%, 57%, and 58%, respectively. Three-week (P = 0.01) and 3-month (P = 0.04) mortality was higher in Child C patients compared to Child B. However, there were no independent predictors of survival on multivariate analysis at 3 or 6 months. Child-Pugh score 3 weeks after TIPS was a strong predictor of mortality. In conclusion, in patients with refractory ascites, TIPS was associated with a high mortality and morbidity. The response and the mortality were both unpredictable on the basis of pretransplant variables.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bories P, Garcia Compean G, Michel H, Bourel M, Capron JP, Gauthier A, Lafon J, Levy VG, Pascal JP, Quinton A, et al: The treatment of refractory ascites by the LeVeen shunt. A multicentre controlled trial (57 patients). J Hepatol 3:212-218, 1986

    Google Scholar 

  2. Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T: Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 47:288-295, 2000

    Google Scholar 

  3. Crenshaw WB, Gordon FD, McEniff NJ, Perry LJ, Hartnell G, Anastopoulos H, Jenkins RL, Lewis WD, Wheeler HG, Clouse ME: Severe ascites: efficacy of the transjugular intrahepatic porto-systemic shunt in treatment. Radiology 200:185-192, 1996

    Google Scholar 

  4. Deschenes M, Dufresne MP, Bui B, Fenyves D, Spahr L, Roy L, Lafortune M, Pomier-Layrargues G: Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 94:1361-1365, 1999

    Google Scholar 

  5. Franco D, Vons C, Traynor O, de Smadja C: Should portosystemic shunt be considered in the treatment of intractable ascites in cirrhotics? Arch Surg 123:987-991, 1988

    Google Scholar 

  6. Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, Gadano A, Lassen C, Benhamou JP, Erlinger S: Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol 25:135-144, 1996

    Google Scholar 

  7. Martinet JP, Fenyves D, Legault L, Roy L, Dufresne MP, Spahr L, Lafortune M, Pomier-Layrargues G: Treatment of refractory ascites using transjugular intrahepatic porto-systemic shunt. Dig Dis Sci 42:161-166, 1997

    Google Scholar 

  8. Nazarian GK, Bjarnason H, Dietz CA Jr, Bernadas CA, Foshager MC, Ferral H, Hunter DW: Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 205:173-180, 1997

    Google Scholar 

  9. Rees CJ, Rose JD, Record CO, Day CP, Bassendine MF, James OF, Hudson M: Transjugular intrahepatic portosystemic shunt: a limited role in refractory ascites. Eur J Gastroenterol Hepatol 9:969-973, 1997

    Google Scholar 

  10. Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, Olschewski M, Reiser M, Gerbes AL: A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 342:1701-1707, 2000

    Google Scholar 

  11. Williams DB, Waugh R, Selby W: Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites. Aust NZ J Med 28:620-626, 1998

    Google Scholar 

  12. Fernandez-Seara J, Prieto J, Quiroga J, Zozaya JM, Cobos MA, Rodriguez-Eire JL, Garcia-Plaza A, Leal J: Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology 97:1304-1312, 1989

    Google Scholar 

  13. Schrier RW, Arroyo V, Bernardi M, Epatein M, Henriksen JH, Rodes J: Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151-1157, 1988

    Google Scholar 

  14. Wong F, Liu P, Allidina Y, Blendis LM: Pattern of sodium handling and its consequences in pre-ascitic cirrhosis. Gastroenterology 108:1820-1827, 1995

    Google Scholar 

  15. Koepke JP, Jones S, DiBona GF: Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats. Am J Physiol 252:R1019-R1023, 1987

    Google Scholar 

  16. Campbell V, Greig P, Cranford J, Langer B, Silverman M, Blendis L: A comparison of acute reversible pre and post-sinusoidal portal hypertension on salt and water retention in the dog. Hepatology 2:54-58, 1982

    Google Scholar 

  17. Morali G, Sniderman K, Deitel KM, Tobe S, Witt-Sullivan H, Simon M, Heathcote J, Blendis LM: Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites. J Hepatol 16:249-250, 1992

    Google Scholar 

  18. Wong F, Blendis L: Transjugular intrahepatic portosystemic shunt for refractory ascites: tipping the sodium balance. Hepatology 22:358-364, 1995

    Google Scholar 

  19. Stanley MM, Ochi S, Lee KK, Nemchausky BA, Greenlee HB, Allen JI, Allen MJ, Baum RA, Gadacz TR, Camara DS: Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med 321:1632-1638, 1989

    Google Scholar 

  20. Bruno S, Borzio M, Romagnoni M, Battezzati PM, Rossi S, Chiesa A, Podda M: Comparison of spontaneous ascites filtration and reinfusion with total paracentesis with intravenous albumin infusion in cirrhotic patients with tense ascites: a randomized study. BMJ 304:1655-1658, 1992

    Google Scholar 

  21. Cadranel JF, Gargot D, Grippon P, Lunel F, Bernard B, Valla D, Opolon P: Spontaneous dialytic ultra filtration with intraperitoneal infusion of the concentrate versus large paracentesis in cirrhotic patients with intactable ascites: a randomized study. Intl J Artif Organs 15:432-435, 1992

    Google Scholar 

  22. Smart HL, Triger DR: A randomized prospective trial comparing daily paracentesis and intravenous albumin with recirculation in diuretic refractory ascites. J Hepatol 10:191-197, 1990

    Google Scholar 

  23. LeVeen HH, Wapnick S, Grosberg S, Kinney MJ: Further experience with peritoneovenous shunt for ascites. Ann Surg 184:574-581, 1976

    Google Scholar 

  24. Smadga C, Franco D: The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis: a prospective study on patients. Ann Surg 201:488-493, 1985

    Google Scholar 

  25. Elcheroth J, Vons C, Franco D: Role of surgical therapy in the management of intractable ascites. World J Surg 18:240-245, 1994

    Google Scholar 

  26. Gines P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimola A, Viver J, Camps J, Jimenez W, Mastai R, Gaya J, Rodes J: Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Gastroenterology 93:234-241, 1987

    Google Scholar 

  27. Gines P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, Hoyos M, Viladomiu L, Rimola A, Morillas R, Salmeron JM, Gines A, Esteban R, Rodes J: Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 325:829-835, 1991

    Google Scholar 

  28. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau J-M, Berger E, Blum U, Gabelmann A, Havenstein K, Langer M, Gerok W: The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330:165-171, 1994

    Google Scholar 

  29. Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis L: The mechanism of initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 112:899-907, 1997

    Google Scholar 

  30. Gerbes AL, Gulberg V, Waggershauser T, Holl J, Reiser M: Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites. Hepatology 28:683-688, 1998

    Google Scholar 

  31. Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, Garcia-Villarreal L, Zozaya JM, Betes M, Herrero JI, Prieto J: Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites-effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 21:986-994, 1995

    Google Scholar 

  32. Guevara M, Gines P, Bandi JC, Gilabert R, Sort P, Jimenez W, Garcia-Pagan JC, Bosch J, Arroyo V, Rodes J: Transjugular intrahepatic portal-systemic shunt in hepatorenal syndrome: effect on renal function and vasoactive systems. Hepatology 28:416-422, 1998

    Google Scholar 

  33. Jalan R, Redhead DN, Thomas HW, Henderson N, O'Rourke K, Dillon JF, Williams BC, Hayes PC: Mechanisms of changes in renal handling following transjugular intrahepatic portosystemic stent-shunt (TIPSS). Eur J Gastroenterol Hepatol 8 (11):1111-1116, 1996

    Google Scholar 

  34. Martinet JP, Legault L, Cernacek P, Roy L, Dufresne MP, Spahr L, Fenyves D, Pomier-Layrargues G: Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites. J Hepatol 25:700-706, 1996

    Google Scholar 

  35. Somberg KA, Lake JR, Tomlanovich SJ, LaBerge JM, Bass NM: Transjugular intrahepatic portosystemic shunt for refractory ascites: assessment of clinical and humoral response and renal function. Hepatology 21:709-716, 1995

    Google Scholar 

  36. Ochs A, Rossle M, Haag K, Hauenstein K-H, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE: The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 332:1192-1197, 1995

    Google Scholar 

  37. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL: Creation of transjugular intrahepatic portosystemic shunts with the Wallstent endoprosthesis: results in 100 patients. Radiology 187:413-420, 1993

    Google Scholar 

  38. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for oesophageal varices. Br J Surg 60:646-649, 1973

    Google Scholar 

  39. Ferral H, Bjarnason H, Wegryn SA, Rengel GJ, Nazarian GK, Rank JM, Tadavarthy SM, Hunter DW, Castaneda-Zuniga WR: Refractory ascites—early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 189:795-801, 1993

    Google Scholar 

  40. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864-871, 2000

    Google Scholar 

  41. Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK: Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal bleeding: a meta-analysis. Hepatology 30:612-622, 1999

    Google Scholar 

  42. Sanyal AJ, Freeman AM, Shiffman ML, Purdum PP, Luketic VA, Cheatham AK: Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective study. Hepatology 20:46-55, 1994

    Google Scholar 

  43. Nolte W, Wiltfang J, Schindler C, Munke H, Unterberg K, Zumhasch U, Figulla HR, Werner G, Hartmann H, Ramadori G: Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology 28:1215-1225, 1998

    Google Scholar 

  44. Pomier-Layrargues G: TIPS and hepatic encephalopathy. Semin Liver Dis 16:315-320, 1996

    Google Scholar 

Download references

Authors
  1. Paul J. Thuluvath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jasdeep S. Bal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sally Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gunnar Lund
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anthony Venbrux
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thuluvath, P.J., Bal, J.S., Mitchell, S. et al. TIPS for Management of Refractory Ascites: Response and Survival Are Both Unpredictable. Dig Dis Sci 48, 542–550 (2003). https://doi.org/10.1023/A:1022544917898

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022544917898

Search

Navigation